LiveRamp Holdings, Inc. has taken significant steps following its recent merger with MMS USA Holdings, Inc. The company filed a post-effective amendment to deregister shares of its common stock that remain unsold under previous registration statements. This move is part of a broader trend in the computer processing and data preparation industry, reflecting ongoing consolidation.
The merger, which became effective on November 2, 2026, positions LiveRamp as a wholly owned subsidiary of MMS USA Holdings. This strategic decision is expected to streamline operations and enhance market competitiveness.
Background
LiveRamp Holdings, Inc. operates within the Services-Computer Processing & Data Preparation sector, specifically under the SIC code 7374. It is publicly traded on the NYSE under the ticker symbol RAMP. The company has undergone several transformations, including a name change from Acxiom Holdings, Inc. in September 2018. Recent filings indicate a series of S-8 forms, which are used for registering employee benefit plans.
What the Filing Says
The filing states, "This Post-Effective Amendment is being filed to withdraw and deregister all shares of common stock... that had been registered and remain unsold under the Registration Statements." This indicates a formal termination of the stock offerings as a result of the merger.
Impact
This deregistration will affect LiveRamp's existing stock offerings and employee compensation plans. As the company integrates into MMS USA Holdings, employees may see changes in their stock options and compensation structures. The broader industry may also feel the impact as competitors assess their own strategies in response to LiveRamp's consolidation.
What's Next
The filing does not specify what happens next for LiveRamp Holdings, but it marks a significant transition for the company as it adapts to its new corporate structure.
Read Next
LOR Inc. Acquires Over 1.4 Million Shares of Rollins Inc.
Brian Magnusson Reports New Stock Transactions at Lindsay Corp
Klein Lawrence Otto Acquires 25,000 Shares in Oruka Therapeutics
Saba Capital Management boosts stake in Ellsworth Growth Fund
Hudson Susan Claire acquires shares in Flowserve Corp.
Agrawal Ajay acquires shares in Flowserve Corp via grant





